Discover Great Companies Discover Great Clients
Popularity  3.4万   |   Followers  7   |   Likes  16 Claim this company
Wuhan East Lake High-Tech Zone Hubei No.10 Animal Health No.17 Yi Chuan Xue No.20 Data Engineering No.56 Research Institute No.69 Xue Shu Yan Jiu No.70 Ke Xue Yan Jiu Sheng Wu Ke Ji / Biotechnology Engineering Big Data Lin Chuang Yi Xue Dan Xi Bao Ce Xu Genes Technology San Dai Ce Xu 高新技术企业 科技型中小企业 企业技术中心 专精特新小巨人企业 省级高新技术企业 省科技型中小企业
More

Company Overview

  • Nature: Private Enterprise Size: 100-499 employees Founded: 15年
  • Industry: Pharmaceuticals/Bioengineering 、 Raw Materials and Processing 、 Academia/Scientific Research
  • Full name: Wuhan Grandomics Biosciences Co., Ltd.。

Development Stage

  • Ranking: Ranked #10 in Wuhan Animal Health Company by popularity
  • Honors: 高新技术企业 科技型中小企业 According to algorithm
  • Salary: 65% of positions earn 8-15K, In 2026 vs last yeardecreased by 32%.。Master's salary: ¥15.0K.
  • Recruiting: In 2026 vs 2025decreased by 52%.
  • Requirement: Education: 硕士 leads with 35%. Experience: 1-3年 leads with 50%.
  • Region: Distributed across 2 regions, 北京: 25%, 武汉: 25%, 上海: 15%, 南昌: 10%.

About the Company

Grandomics is a pioneer in third-generation sequencing big data technology and applications. Founded on August 8, 2011, it initially used the brand "Future Genomics" to promote third-generation sequencing technology services. It is a third-generation sequencing service company and a third-generation sequencing big data diagnostics company. For many years, it has been focusing on technology development and application expansion on third-generation sequencing platforms. At present, it has formed four major business modules: "Technology Services", "Medical Diagnostics", "Bioinformatics", and "Advanced Manufacturing"; it has built a total of more than 5,000 square meters of scientific research service platforms and medical testing laboratories in Beijing and Wuhan; it has introduced internationally advanced technology platforms such as ONT PromethION 48, PacBio Sequel II, MGISEQ2000/T7, and Bionano Saphyr optical mapping. The company insists on technological innovation and has independently developed the NextDenovo/NextPolish series of third-generation sequencing assembly software, the GrandVariants (GrandSV/GrandSTR, etc.) third-generation sequencing genome variation analysis system software, the GrandPathogen pathogenic microorganism detection software, the GrandBox genetic disease big data analysis system software, SCAN-seq third-generation sequencing single-cell sequencing technology, Grand-C next-generation three-dimensional genomics technology, and the dbSV human genome structural variation database; at the same time, it has built a Huawei Cloud third-generation sequencing high-performance computing cluster to provide customers with high-quality third-generation sequencing analysis and storage services. The company's core team consists of senior experts in third-generation sequencing technology and applications with many years of experience, and more than 50% of them hold master's or doctoral degrees. In the 2020-2024 Nature Index annual rankings, Grandomics was listed for consecutive years. From 2019 to 2022, it was consecutively awarded "Future Healthcare 100 - China Medical Services Top 100". In 2024, it was recognized as a "Five-Star High-Tech Enterprise" by Wuhan. The company has successively received investments from well-known domestic investment institutions such as Matrix Partners China, SAIF Partners, Zero2IPO Capital, Yuanyi Capital, and Chang Development Investment, becoming a high-quality brand in China's third-generation sequencing sector.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Grandomics Biosciences How Fast Is Hiring Growing?

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Down 39%
  • 2024: Down 59%
  • 2023: Up 166%
  • 2022: Down 39%
Grandomics Biosciences Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
No.3917
Recruitment Growth Ranking in Wuhan 򀀩
Note: How fast is hiring at Wuhan Grandomics Biosciences Co., Ltd. growing? Grandomics Biosciences2026: 11 openings (down 52%), 2025: 23 openings (down 39%), 2024: 38 openings (down 59%), 2023: 93 openings (up 166%), 2022: 35 openings (down 39%), 2021: 57 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Grandomics Biosciences — What Are the Salaries Like? (20 records)

Manage
Grandomics Biosciences Salary Overview
salary range: 2K - 30K, 65% of roles pay ¥8-15K
Note: salary statistics are based on 20 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Wuhan Grandomics Biosciences Co., Ltd.?Grandomics Biosciences65% of positions earn 8-15K, Undergraduate salary: ¥。Wuhan salary ranking top 40,Sales average salary ¥12.8K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Grandomics Biosciences

(More)
Are salaries high at Wuhan Grandomics Biosciences Co., Ltd.? We provide: Sales, Account Manager, Business Development, Accountant, Information, Analyst, 合作经理, Business Partnerships, Key Account, Intern, Laboratory Technician, Business Development, Management Manager, Operations Engineer, Project Management. Click to view detailed salary analysis by job.

Grandomics Biosciences honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Job Category

  • Sales
    75% of total 75%
  • Scientific Research
    10% of total 10%
  • Business Management
    10% of total 10%
  • Computer/Network/Technology
    10% of total 10%

Education

  • 硕士
    35% of total 35%
  • 大专
    30% of total 30%
  • 本科
    30% of total 30%
  • 不限
    5% of total 5%

Experience

  • 1-3年
    50% of total 50%
  • 不限
    25% of total 25%
  • 5-10年
    15% of total 15%
  • 3-5年
    10% of total 10%
View Detailed Analysis

What does Wuhan Grandomics Biosciences Co., Ltd. require? Who is Grandomics Biosciences hiring? Grandomics Biosciences recruitment: Sales占比最多占75%,其次是Scientific Research占10%. What education can get in at Grandomics Biosciences? 硕士占比最多占35%,其次是大专占30%. High education required at Grandomics Biosciences? 硕士占35%. Work experience required at Grandomics Biosciences? 1-3年占比最多占50%,其次是不限占25%. Where are the job locations at Grandomics Biosciences? 北京占比最多占25%,其次是武汉占25%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 5,000万(元)
Legal Representative: 汪德鹏
Date Established:
Credit Code: 9142010057829106XN
Registered Address: 武汉市东湖新技术开发区花城大道8号武汉软件新城二期C11栋18层01号-2

People who follow Grandomics Biosciences also follow

Grandomics Biosciences Competitors (Similar Companies)

生物科技/生物工程 医药 生命科学 生命科学研究
生物科技/生物工程 生物信息 研究院/研究所 科研机构
生物科技/生物工程 医药 蛋白表达 诊断试剂
医药 生物医药 单克隆抗体药物 高通量筛选
医疗器械 实验室设备 技术转让 定制
“Developer of molecular diagnostic instruments and reagents”
生物科技/生物工程 高通量测序 单细胞测序 腺苷
生命科学 生物信息 生物信息学 科研服务
系统集成 移动智能终端 系统工程 多媒体技术
生物科技/生物工程
农业 粮油食品 农产品加工 食品
试剂 生命科学 生命科学研究 科学研究
生物科技/生物工程 气象观测 生命科学 临床医学
国内游 旅游服务 旅游线路 国内旅游

Discover Great Companies, Discover Great Clients

武汉公司名录 武汉“East Lake High-tech Zone”公司名录 武汉“生物科技/生物工程”公司名录 武汉“研究院/研究所”公司名录 武汉“科学研究”公司名录 武汉“临床医学”公司名录 武汉“动物保健”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates